Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches

Summary

Crossover study of DFN-15 dose A versus DFN-15 dose B versus Placebo in the treatment of migraine headaches.

Timeline

Start

2015-06-05

Primary completion

2015-12-01

Completion

2016-05-05

Publications

• Results Munjal S, Bennett A. Efficacy and safety of DFN-15, an oral liquid formulation of celecoxib, in adults with migraine: a multicenter, randomized, placebo-controlled, double-blind, crossover study. Neuropsychiatr Dis Treat. 2017 Nov 7;13:2797-2802. doi: 10.2147/NDT.S151834. eCollection 2017.

Drugs

Indications